Skip to main content
. 2019 Mar 13;10:1203. doi: 10.1038/s41467-019-09174-1

Fig. 4.

Fig. 4

Runx2 acts as a mediator of the pro-calcifying effects of PARP1. a Western blot analysis of several osteogenic factors expression in calcified VSMCs transfected with Scr or PARP1 shRNA. (n = 5 per group). b The expression levels of Runx2 and SMA in abdominal arteries of indicated groups were determined by immunofluorescence staining. (n = 5 per group). Scale bar, 100 μm. ce Rat abdominal aortas were inoculated with Ad-Scr shRNA, or Ad-Runx2 shRNA together with Ad-Null or Ad-PARP1 at three weeks after the adenine diet. Six weeks later, arteries were isolated and the calcification was analyzed by H&E, von Kossa staining (c) and the calcium quantification (d) (n = 10–12 per group), and the downstream osteogenic markers (OPN, ColIA1, OC, and Runx2) were analyzed by western blot (e). (n = 5 per group). Scale bar, 100 μm. f, g The aortic rings (f) or rVSMCs (g) were pre-infected with Ad-Scr shRNA, or Ad-Runx2 shRNA together with Ad-Null or Ad-PARP1, and exposed to the osteogenic medium for 14 days. The calcification was determined by the calcium assay respectively. (n = 5 for each group). Statistical significance was assessed using one-way ANOVA for multiple comparison and is presented as follows: NS: no significance, **P < 0.01 and ##P < 0.01. All values are means ± S.D. Source data are provided as a Source Data file